Home Home Home Inbox Home Search

Event

Fevipiprant, a Selective Prostaglandin D2 Receptor 2 Antagonist, Potently Inhibits Chemotaxis and Cytokine Production by Group 2 Innate Lymphoid Cells [Board No. 415]

Location: Board no. 415
Session Type: RAPiD: Rapid Abstract Poster Discussion Session
Tuesday
May
22
2:15 PM
4:15 PM

Speaker(s)/Author(s)

Veit Johannes. Erpenbeck

MD, PhD
Novartis;Novartis Pharma AG

David Sandham

PhD
Novartis Institutes for Biomedical Research

Paul Batty

BA
University of Oxford

Clare Hardman

Post-doc
MRC Human Immunology Unit;University of Oxford

Luzheng Xue

PhD
University of Oxford

Wentao Chen

MSc
University of Oxford

Graham Ogg

DPhil, FRCP
MRC Human Immunology Unit;University of Oxford

View Abstract

Fevipiprant, a Selective Prostaglandin D2 Receptor 2 Antagonist, Potently Inhibits Chemotaxis and Cytokine Production by Group 2 Innate Lymphoid Cells

Parent Sessions

  • C101 - ASTHMA CLINICAL AND MECHANISTIC STUDIES...
    05-22-2018 2:15 PM - 4:15 PM
    • Home Home Home Inbox Home Search